CompoAtlas

Herbesan Desmodium Bien-être du foie

Food supplement declared in France, declaration No 2017-7-697

Herbesan Desmodium Bien-être du foie, from LABORATOIRES SUPER DIET, is a food supplement declared in France. Status: withdrawn from the market on 26 June 2026. Main ingredients: Raphanus raphanistrum 7627.5 mg per day, Desmodium adscendens 300 mg per day, Cynara scolymus 255 mg per day, Rosmarinus officinalis 50 mg per day, Cynara scolymus 45 mg per day. None of the rules we check flags an issue with its declared composition.

Brand
Herbesan
Food business operator placing the product on the market
LABORATOIRES SUPER DIET
Status
Withdrawn from the market on 26 June 2026
Form
Ampoule
Daily dose
1 ampoule par jour
Directions for use
pure ou diluée dans un demi-verre d'eau.
Not recommended (according to the manufacturer)
Adolescents (under 18), Breastfeeding women, Children (under 12), Pregnant women, Taking thyroid medication
Objectives stated by the manufacturer (these are not authorised claims)
Detox / Drainage

Declaration 282425, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Raphanus raphanistrum subsp. sativus (L.) DominRacineAutre extrait fluide7627.5 mg
Desmodium adscendens (Sw.) DC.FeuilleExtrait fluide aqueux300 mg
Cynara scolymus L.FeuilleExtrait sec aqueux255 mg
Rosmarinus officinalis L.FeuilleExtrait fluide aqueux50 mg
Cynara scolymus L.FeuilleExtrait fluide aqueux45 mg

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Autre consommation déconseillée : Ne convient pas en cas d'allergie à l'artichaut ou aux Astéracées. Déconseillé en cas de calculs biliaires. Déconseillé en cas d’hypothyroïdie ou de traitement de la thyroïde, consultez préalablement un professionnel de santé.Réservé à l'adulte. Si vous suivez un traitement, demandez l'avis de votre médecin.

Regulatory points

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Rosmarinus officinalis L.
    Read the warning, when it applies and the studies cited

    ROSEMARY – ROSMARINUS OFFICINALIS Oral

    Route of administration: Oral (ESCOP 2003)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Contraindications

    Do not use if you are pregnant or breastfeeding (Gardner and McGuffin 2013; Brinker 2010; Barnes et al. 2007; Blumenthal et al. 2000).

    Sources cited by Health Canada (4)
    • Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): The Pharmaceutical Press; 2007.
    • Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Gardner Z, McGuffin M, editors. American Herbal Products Association’s Botanical Safety Handbook. 2nd edition. Boca Ration (FL): Taylor and Francis Group; 2013.

    Health Canada monograph dated 29 May 2026

    ROSEMARY - ROSMARINUS OFFICINALIS Topical

    Route of administration: Topical (ESCOP 2003)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Gardner and McGuffin 2013; Brinker 2010; Barnes et al. 2007; Blumenthal et al. 2000).

    Sources cited by Health Canada (4)
    • Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): The Pharmaceutical Press; 2007.
    • Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Gardner Z, McGuffin M, editors. American Herbal Products Association’s Botanical Safety Handbook. 2nd edition. Boca Ration (FL): Taylor and Francis Group; 2013.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have large open wounds, skin lesions, feverish conditions, acute inflammation, severe circulatory disorders or hypertension (ESCOP 2003).

    Sources cited by Health Canada (1)
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (Barnes et al. 2007; ESCOP 2003).

    Sources cited by Health Canada (2)
    • Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): The Pharmaceutical Press; 2007.
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.

    Health Canada monograph dated 29 May 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Brand : Herbesan

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Herbesan Desmodium Bien-être du foie: composition and regulation”, https://compoatlas.com/en/supplements/products/282425-herbesan-desmodium-bien-etre-du-foie, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line